The Latest Breaking News from FDA

Given the growing demand for healthcare facilities, rapid integration of digital technology, and transformative biotechnology breakthroughs, the medical industry is poised for continued growth and profitability this year and beyond. Amid this, let’s find out why investors are flocking to medical stocks Vertex Pharmaceuticals (VRTX) and McKesson (MCK). Read more….

A research paper that raises questions about the safety of abortion has been retracted. The research is cited in a federal judge's ruling about the abortion pill mifepristone.

“I hope that this will make people more careful about when they cite studies," one lawyer told Salon

In 2024, the FDA will decide whether or not MDMA can be used to treat patients suffering from PTSD.

The myriad potential harms of these products are wide-ranging

The FDA will soon move to ban formaldehyde in hair-straightening products. It's more than a decade after research raised alarms about health risks and other worrying chemicals remain in the products.

“The Maharashtra Food and Drug Administration (FDA) has exposed a bogus medicine racket and seized 21,600 tablets that had been passed off as ‘antibiotic ciprofloxacin’ from a government hospital in Nagpur,” an official said.

Reports indicate the annual trend of giving up alcohol in January can help increase recreational cannabis sales.

Terry Dubrow, star of Botched, advocates for the use of Ozempic for weight loss, claiming it is safer than Tylenol and effective in treating obesity.

The pharmaceutical industry holds immense promise due to the rapidly aging population, growing healthcare needs, breakthroughs in new drugs and therapies, and the rise in chronic diseases. Therefore, it could be wise to add fundamentally strong pharma stocks Supernus Pharmaceuticals (SUPN), Eton Pharmaceuticals (ETON), and Viatris (VTRS) to one’s portfolio.…

The Federal Trade Commission has challenged more than 100 patents drugmakers listed in the FDA’s “Orange Book"